# Contemporary Pediatrics

> Contemporary Pediatrics - Healthcare Publication

- Base URL: https://www.contemporarypediatrics.com
- Generated: 2026-10-21T01:17:28.750Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.contemporarypediatrics.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.contemporarypediatrics.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.contemporarypediatrics.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.contemporarypediatrics.com/robots.txt](https://www.contemporarypediatrics.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [AAP News](https://www.contemporarypediatrics.com/aap-guidelines)
- [Around The Practice](https://www.contemporarypediatrics.com/around-the-practice)
- [Case Studies](https://www.contemporarypediatrics.com/case-studies)
- [Clinical](https://www.contemporarypediatrics.com/clinical)
- [Editorial Podcasts](https://www.contemporarypediatrics.com/editorial-podcasts)
- [Insights](https://www.contemporarypediatrics.com/insights)
- [MJH Broadcast Channel](https://www.contemporarypediatrics.com/mjh-broadcast-channel)
- [News](https://www.contemporarypediatrics.com/news)
- [Peers & Perspectives](https://www.contemporarypediatrics.com/peers-perspectives)
- [Podcasts](https://www.contemporarypediatrics.com/podcasts)
- [Publications](https://www.contemporarypediatrics.com/publications/[journal]/[year]/[issue])
- [Resources](https://www.contemporarypediatrics.com/resources)
- [Toolkits](https://www.contemporarypediatrics.com/toolkits)
- [Video Series](https://www.contemporarypediatrics.com/video-series)
- [Viewpoints](https://www.contemporarypediatrics.com/viewpoints)

## Featured Content

- [Recognizing skin conditions in children with darker skin tones](https://www.contemporarypediatrics.com/view/recognizing-skin-conditions-in-children-with-darker-skin-tones): Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment g...
- [Tezepelumab sustains EoE remission through 52 weeks ](https://www.contemporarypediatrics.com/view/tezepelumab-sustains-eoe-remission-through-52-weeks): Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.
- [Black children face higher odds of T2-high severe asthma](https://www.contemporarypediatrics.com/view/black-children-face-higher-odds-of-t2-high-severe-asthma): Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.
- [Testosterone changes linked to emotional distress in pubertal girls](https://www.contemporarypediatrics.com/view/testosterone-changes-linked-to-emotional-distress-in-pubertal-girls): Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatri...
- [4 in 5 parents say baby costs are too high, most back paid leave](https://www.contemporarypediatrics.com/view/4-in-5-parents-say-baby-costs-are-too-high-most-back-paid-leave): A Mott Poll of 2,027 parents found 81% say having a baby costs too much; 73% strongly back state paid leave around birth.
- [Mirikizumab meets 1-year remission end point in pediatric UC](https://www.contemporarypediatrics.com/view/mirikizumab-meets-1-year-remission-end-point-in-pediatric-uc): In phase 3 SHINE-2, 50% of mirikizumab induction responders aged 6 to 17 with moderate to severe UC were in clinical remission at week 52.
- [Contemporary Pediatrics week in review: October 12-16, 2026](https://www.contemporarypediatrics.com/view/contemporary-pediatrics-week-in-review-october-12-october-16-2026): Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
- [Starting solids: When to begin, what to offer, and how much](https://www.contemporarypediatrics.com/view/starting-solids-when-to-begin-what-to-offer-and-how-much): Learn when your baby is ready for solids, choose safe purees or finger foods, prevent choking, prioritize iron, and introduce allergens confidently.
- [Infant skin care: Choosing products that protect the skin barrier](https://www.contemporarypediatrics.com/view/infant-skin-care-choosing-products-that-protect-the-skin-barrier): Christina Boull, MD, shares recommendations for infant skin care, including choosing gentle cleansers, avoiding irritants, and supporting the skin bar...
- [DTaP 96% effective against pertussis in Alaska outbreak](https://www.contemporarypediatrics.com/view/dtap-96-effective-against-pertussis-in-alaska-outbreak): Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.

## Feeds and Indexes

- [RSS Feed](https://www.contemporarypediatrics.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.contemporarypediatrics.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.contemporarypediatrics.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.contemporarypediatrics.com/authors): Browse all contributors and their published work